Prime–boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X
- 1 October 2016
- journal article
- Published by Elsevier in Virus Research
- Vol. 225, 82-90
Abstract
No abstract availableKeywords
Funding Information
- AIRC IG
- Project of Mutual Collaboration of the Planning Department of the National Health Service
This publication has 45 references indexed in Scilit:
- A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancersJournal of Translational Medicine, 2015
- Design of a Highly Effective Therapeutic HPV16 E6/E7-Specific DNA Vaccine: Optimization by Different Ways of Sequence Rearrangements (Shuffling)PLOS ONE, 2014
- Anti-tumor effects of genetic vaccines against HPV major oncogenesHuman Vaccines & Immunotherapeutics, 2014
- Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strainVirus Research, 2013
- Expression of a recombinant Human papillomavirus 16 E6GT oncoprotein fused to N- and C-termini of Potato virus X coat protein in Nicotiana benthamianaPlant Cell, Tissue and Organ Culture (PCTOC), 2012
- Multifunctional T-Cell Characteristics Induced by a Polyvalent DNA Prime/Protein Boost Human Immunodeficiency Virus Type 1 Vaccine Regimen Given to Healthy Adults Are Dependent on the Route and Dose of AdministrationJournal of Virology, 2008
- Plasmid DNA and viral vector-based vaccines for the treatment of cancerVaccine, 2007
- Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccinesVaccine, 2000
- Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine.Journal of General Virology, 1998
- Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells.Journal of General Virology, 1998